Key result
RGS10 overexpression ameliorates hypoxia-induced pulmonary hypertension in mice by suppressing the AKT/mTORC1 axis.
Why the study?
Excessive proliferation and migration of PASMC is a core event of pulmonary hypertension, and the regulatory role of RGS10 in PH was unclear.
Does RGS10 overexpression inhibit PASMC proliferation and migration and ameliorate pulmonary hypertension in preclinical models?
Does RGS10 overexpression inhibit PASMC proliferation and migration and ameliorate pulmonary hypertension in preclinical models?
RGS10 overexpression inhibits pulmonary arterial smooth muscle cell proliferation and migration via the AKT/mTORC1 axis, suggesting a potential therapeutic target for pulmonary hypertension.
Hypothesis-generating for RGS10 in pulmonary hypertension; leaves open translation beyond mouse models.
Objective: Excessive proliferation and migration of pulmonary arterial smooth muscle cell (PASMC) is a core event of pulmonary hypertension (PH). Regulators of G protein signaling 10 (RGS10) can regulate cellular proliferation and cardiopulmonary diseases. We demonstrate whether RGS10 also serves as a regulator of PH.Methods: PASMC was challenged by hypoxia to induce proliferation and migration. Adenovirus carrying Rgs10 gene (Ad-Rgs10) was used for external expression of Rgs10. Hypoxia/SU5416 or MCT was used to induce PH. Right ventricular systolic pressure (RVSP) and right ventricular hypertrophy index (RVHI) were used to validate the establishment of PH model.Results: RGS10 was downregulated in hypoxia-challenged PASMC. Ad-Rgs10 significantly suppressed proliferation and migration of PASMC after hypoxia stimulus, while silencing RGS10 showed contrary effect. Mechanistically, we observed that phosphorylation of S6 and 4E-Binding Protein 1 (4EBP1), the main downstream effectors of mammalian target of rapamycin complex 1 (mTORC1) as well as phosphorylation of AKT, the canonical upstream of mTORC1 in hypoxia-induced PASMC were negatively modulated by RGS10. Both recovering mTORC1 activity and restoring AKT activity abolished these effects of RGS10 on PASMC. More importantly, AKT activation also abolished the inhibitory role of RGS10 in mTORC1 activity in hypoxia-challenged PASMC. Finally, we also observed that overexpression of RGS10 in vivo ameliorated pulmonary vascular wall thickening and reducing RVSP and RVHI in mouse PH model.Conclusion: Our findings reveal the modulatory role of RGS10 in PASMC and PH via AKT/mTORC1 axis. Therefore, targeting RGS10 may serve as a novel potent method for the prevention against PH.”
No takes yet. Share an insight, caveat, or question.
Hu et al. (2023) studied Pulmonary hypertension. RGS10 overexpression (Ad-Rgs10) vs. Hypoxia or silencing RGS10 was evaluated on Proliferation and migration of PASMC, right ventricular systolic pressure (RVSP), and right ventricular hypertrophy index (RVHI). Overexpression of RGS10 suppressed hypoxia-induced proliferation and migration of pulmonary arterial smooth muscle cells and ameliorated pulmonary hypertension in a mouse model via the AKT/mTORC1 axis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: